J&J Inks Settlements In 76 Topamax Birth Defect Suits

Law360, Philadelphia (April 4, 2014, 3:16 PM EDT) -- A Johnson & Johnson unit has inked settlement deals with plaintiffs in 76 suits in Pennsylvania court over alleged birth defects in the babies of women who took the anti-epilepsy and migraine drug Topamax during their pregnancies, according to an order filed Tuesday.

Judge Arnold New, who is coordinating a mass tort docket of Topamax cases in the Philadelphia County Court of Common Pleas, filed an order marking 76 cases in the program as discontinued after he received word that plaintiffs had reached settlement deals with Janssen Pharmaceuticals Inc.

An attorney representing plaintiffs in the bulk of the cases marked as...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!